nitroglycerin has been researched along with 6-ketoprostaglandin f1 alpha in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (64.71) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, N; Lefer, AM; Mulloy, D | 1 |
| Kawaguchi, H; Takahashi, K; Yasuda, H | 1 |
| Bennett, A; Melhuish, PB; Stamford, IF | 1 |
| Block, PC; Machaj, V; Palacios, I; Peterson, MB; Philbin, D; Watkins, WD | 1 |
| Punzengruber, C; Silberbauer, K; Sinzinger, H | 1 |
| Lefer, AM; Osborne, JA; Sun, JZ; Yanagisawa, A | 1 |
| De Caterina, R; Dorso, CR; Tack-Goldman, K; Weksler, BB | 1 |
| Brigmon, L; Faro, R; Mehta, J; Mehta, P; Ostrowski, N; Roberts, A | 1 |
| Poincelot, B; Russo-Marie, F | 1 |
| Fitzgerald, DJ; FitzGerald, GA; Robertson, RM; Roy, L | 1 |
| Kong, DL; Levine, FH; Liapis, CD; Nieminen, MT; Nugent, WC; Peterson, MB; Philbin, DM; Watkins, WD | 1 |
| Ito, T; Kai, I; Ogawa, K | 1 |
| Hirai, K; Kobayashi, T; Koizumi, T; Kubo, K; Sakai, A; Sekiguchi, M; Shinozaki, S | 1 |
| Currie, MG; Mollace, V; Salvemini, D | 1 |
| Alam, MS; Hanada, T; Iwasaki, S; Ku, K; Nakayama, K; Nosaka, S; Oku, H; Saitoh, Y; Xu, G | 1 |
| Ishibashi, Y; Ishinaga, Y; Kin, H; Kinoshita, Y; Kitamura, J; Murakami, R; Murakami, Y; Shimada, T | 1 |
| Braun-Dullaeus, RC; Feussner, M; Grimminger, F; Haberbosch, W; Hopmann, H; Kraemer, HJ; Tillmanns, H; Walker, G | 1 |
17 other study(ies) available for nitroglycerin and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Male; Myocardial Reperfusion; Nitric Oxide; Nitroglycerin; Polydeoxyribonucleotides; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Superoxide Dismutase; Superoxides | 1990 |
The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Thromboxane B2; Verapamil | 1989 |
Nitrates do not affect prostacyclin formation by rat arteries: this is unrelated to increased vascular prostacyclin formation with age.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Animals; Arteries; Epoprostenol; In Vitro Techniques; Isosorbide Dinitrate; Male; Muscle, Smooth, Vascular; Nitrates; Nitroglycerin; Rats; Rats, Inbred Strains | 1987 |
Thromboxane release during percutaneous transluminal coronary angioplasty.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Coronary Vasospasm; Coronary Vessels; Humans; Male; Middle Aged; Nitroglycerin; Postoperative Complications; Prospective Studies; Thromboxanes | 1986 |
[Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angina Pectoris; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Epoprostenol; Exercise Test; Female; Hemodynamics; Humans; Indomethacin; Male; Middle Aged; Nitroglycerin; Prostaglandins; Prostaglandins E | 1986 |
Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Adenosine Diphosphate; Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Vessels; Endothelium, Vascular; Epoprostenol; Male; Muscle, Smooth, Vascular; Nitroglycerin; Norepinephrine; Perfusion; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 1987 |
Nitrates and endothelial prostacyclin production: studies in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Vessels; Cells, Cultured; Endothelium; Epoprostenol; Humans; In Vitro Techniques; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Thromboxane B2; Vasodilator Agents | 1985 |
Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Ferricyanides; Humans; In Vitro Techniques; Indomethacin; Methacrylates; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Prostaglandin Antagonists; Prostaglandins; Saphenous Vein; Stimulation, Chemical; Thromboxane-A Synthase | 1983 |
[Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cells, Cultured; Coronary Disease; Epoprostenol; Molsidomine; Nitroglycerin; Oxadiazoles; Radioimmunoassay; Swine; Sydnones | 1983 |
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angina Pectoris; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Epinephrine; Epoprostenol; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Nitroglycerin; Platelet Aggregation | 1984 |
Prostaglandin response to intravenous nitroglycerin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Epoprostenol; Hemodynamics; Infusions, Parenteral; Nitroglycerin; Prostaglandins; Thromboxane A2; Thromboxane B2; Thromboxanes | 1982 |
Effects of peripheral vasodilation caused by verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Dinoprost; Dogs; Female; Male; Nifedipine; Nitroglycerin; Prostaglandins; Prostaglandins E; Prostaglandins F; Pyridines; Thromboxane B2; Thromboxanes; Vascular Resistance; Vasodilation; Verapamil | 1982 |
Effects of continuous infusion of nitroglycerin on pulmonary hemodynamics, lung lymph balance, and prostanoid products in the response to endotoxin in awake sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Consciousness; Endotoxins; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Lymph; Lymphatic System; Nitroglycerin; Pulmonary Circulation; Sheep; Thromboxane B2; Time Factors | 1993 |
Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Aorta; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Hemoglobins; Humans; Kinetics; Male; Methylene Blue; Models, Cardiovascular; Molsidomine; Nitric Oxide; Nitroglycerin; Nitroprusside; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Vasodilation; Vasodilator Agents; Verapamil | 1996 |
Influences of dietary omega-3 polyunsaturated fatty acids on the recovery of cardiac and renal functions after preservation in hyperlipidemic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Cholesterol, Dietary; Dietary Fats, Unsaturated; Eating; Fatty Acids, Omega-3; Female; Glucose; Heart; Hyperlipidemias; Kidney; Lipids; Nitroglycerin; Organ Preservation; Rats; Rats, Wistar; Reperfusion; Serotonin; Thromboxane B2; Tromethamine | 1997 |
Transcardiac 5-hydroxytryptamine release and impaired coronary endothelial function in patients with vasospastic angina.
Topics: 6-Ketoprostaglandin F1 alpha; Angina, Unstable; Blood Platelets; Blood Pressure; Cardiac Catheterization; Catecholamines; Cell Degranulation; Electrocardiography, Ambulatory; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide Donors; Nitroglycerin; Serotonin | 1998 |
Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Cyclooxygenase Inhibitors; Cyclosporine; Endothelium, Vascular; Heart; Heart Rate; Immunosuppressive Agents; Male; Myocardial Contraction; Myocardium; Nifedipine; Nitric Oxide Donors; Nitroglycerin; Pharmaceutical Vehicles; Polyethylene Glycols; Prostanoic Acids; Rats; Rats, Wistar; Receptors, Thromboxane; Thromboxane B2; Vasoconstrictor Agents; Vasodilator Agents | 1999 |